Recruitment

Recruitment Status
Completed
Estimated Enrollment
72

Inclusion Criterias

Patients aged ≥20 years with severe degenerative AS presenting concentric remodeling of the LV, who were scheduled for AVR
Patients aged ≥20 years with severe degenerative AS presenting concentric remodeling of the LV, who were scheduled for AVR

Exclusion Criterias

coronary stenosis ≥70%,
diabetes mellitus,
upper arm peripheral vascular disease,
...
coronary stenosis ≥70%,
diabetes mellitus,
upper arm peripheral vascular disease,
renal failure (serum creatinine > 2.0 mg/dL),
LV ejection fraction <50%

Summary

Conditions
Patients With Elective Aortic Valve Replacement
Type
Interventional
Phase
Phase 4
Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: Double (Investigator, Outcomes Assessor)
  • Primary Purpose: Prevention

Participation Requirements

Age
Between 20 years and 90 years
Gender
Both males and females

Inclusion Criterias

Patients aged ≥20 years with severe degenerative AS presenting concentric remodeling of the LV, who were scheduled for AVR
Patients aged ≥20 years with severe degenerative AS presenting concentric remodeling of the LV, who were scheduled for AVR

Exclusion Criterias

coronary stenosis ≥70%,
diabetes mellitus,
upper arm peripheral vascular disease,
...
coronary stenosis ≥70%,
diabetes mellitus,
upper arm peripheral vascular disease,
renal failure (serum creatinine > 2.0 mg/dL),
LV ejection fraction <50%

Locations

Seoul, 120-752
Seoul, 120-752

Tracking Information

NCT #
NCT01946087
Collaborators
Not Provided
Investigators
Not Provided